Orthobiologics Market|Stryker Corporation, Zimmer Biomet Holdings, Inc., Wright Medical Group

 Regenerative cellular therapies are another name for orthobiologics. Orthobiologics products contain or produce growth factors to aid tissue repair, reduce pain, and help restore normal function. There are many distinct forms of orthobiologics on the market, each with its own mode of action. Autologous stem cells are produced from the patient's own body and divide under the correct conditions to form progenitor cells. Orthobiologics are used to treat a variety of ailments, including fracture rehabilitation, spinal fusion, and more. Hips, knees, ankles, spines, wrists, and other body parts are also accessible. 

From 2018 to 2025, the global orthobiologics market is expected to grow at a CAGR of 4.3 percent, from $4,870 million in 2017 to $6,870 million in 2025.

The rise in the global geriatric population, which is more susceptible to diseases like osteoarthritis and others, is fueling the expansion of the orthobiologics market. Other factors projected to drive market growth include increased awareness of orthobiologics and increased demand for improved therapy. Other important reasons driving the growth of the orthobiologics market are the rise in obesity and the number of sports and road accidents.

Furthermore, during the projected period, strong development potential in developing countries and an increase in demand for sophisticated treatment are expected to generate new possibilities for market competitors.

The global orthobiologics market is divided into product, application, type, end user, and geographic segments. Demineralized bone matrix (DBM), allograft, bone morphogenetic protein (BMP), Viscosupplementation products, synthetic bone substitutes, and others are the different types of items in the market. The market is divided into knee, ankle, hip, wrist & shoulder, spine, and others based on kind. The market is segmented into three types of end users: hospitals and ambulatory centres, research and academic institutes, and dentistry clinics. The market is further segmented by application into osteoarthritis and degenerative arthritis, spinal fusion, fracture recovery, soft tissue injuries, and maxillo-facial injuries.

It is studied in North America (the United States, Canada, and Mexico), Europe (Germany, France, the United Kingdom, Italy, Spain, and the rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and the rest of Asia-Pacific), and LAMEA (Latin America, Middle East, and Africa) (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Stryker Corporation, Zimmer Biomet Holdings, Inc., Wright Medical Group, Inc., Integra LifeSciences Holdings Corporation, Arthrex, Inc. (Arthrex), Johnson and Johnson (J&J), Exactec Inc., Medline Industries, Inc., Globus Medical, Inc., and NuVasive Inc. are some of the major competitors in the industry.